Cencora Expands Enterprise Leadership Team with Two Senior Appointments
Francois Mandeville Named Executive Vice President, Strategy and M&A
Pawan Verma Appointed Executive Vice President, Chief Data and Information Officer
"We’re thrilled to welcome Francois and Pawan to Cencora’s leadership team,” said
As EVP, Strategy and M&A, Mandeville will be responsible for overseeing Cencora’s M&A and strategy execution to ensure the company is investing in businesses that bring new solutions to meet customers’ needs. Mandeville has a long and distinguished career leading M&A strategies to drive business growth, having most recently served as Chief Development Officer at Johnson Controls. Prior to that, he worked at Danaher Corporation as SVP, Strategy & Business Development, where he was responsible for creating strategies that propelled the business’s growth from
As EVP, Chief Data and Information Officer, Verma will oversee Cencora’s efforts to accelerate its digital transformation, while driving innovation to improve operations. Verma’s appointment further reinforces Cencora’s commitment to elevating its digital capabilities to equip customers and employees with advanced tools and technologies. Verma has a tenured history and proven track record of helping global organizations navigate technological transformation and modernization. He joined Cencora from MetLife, where he most recently served as EVP and Global Chief Information Officer, overseeing an organization of 10,000 people, and spearheading the company’s differentiated digital experience. Prior to that, he served as Chief Information and Customer Experience Officer at Foot Locker, leading a 4,000-member team to transform technology, data, and supply chain ecosystems. Verma's work earned him the Forbes CIO Innovation Award. He has also held significant roles at Target,
About Cencora
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than
View source version on businesswire.com: https://www.businesswire.com/news/home/20241104808329/en/
Investors:
Senior Vice President, Head of Investor Relations &
610-727-3693
bennett.murphy@cencora.com
Media:
610-545-9189
Mike.Iorfino@cencora.com
Source: Cencora